Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 — Denver, Colorado

Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328?

Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 conducted?

Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL).

Is Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 accredited by Crixeo Health?

Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.